Labcorp to expand bioanalytical services with integrated laboratory in singapore

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced the expansion of its drug development offering in the asia-pacific region with the addition of bioanalytical services in singapore. “singapore is a crucial region for strengthening labcorp's extensive global presence, offering our clients—both in-region and international—a complementary site to support their bioanalytical studies,” said stephane sidobre, vice president and head of labc
LH Ratings Summary
LH Quant Ranking